Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Carilion Biomedical Institute (CBI) was a non-profit organization established as a joint venture between Carilion Health System, Virginia Tech, and the University of Virginia. Founded in 1999, its primary mission was to foster collaborative research and development in the biomedical sciences and to promote economic development in Western Virginia. CBI provided seed funding and resources for early-stage biomedical technologies, particularly in medical imaging, bioinformatics, and biotechnology. The institute served as a critical precursor to the formal partnership between Virginia Tech and Carilion Clinic, which eventually led to the creation of the Virginia Tech Carilion School of Medicine and the Fralin Biomedical Research Institute. By bridging the gap between academic research and clinical application, CBI laid the groundwork for the current life sciences ecosystem in the Roanoke region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carilion Biomedical Institute.